WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H561653
CAS#: 76-66-4
Description: Rhynchophylline is a non-competitive NMDA antagonist and calcium channel blocker.
Hodoodo Cat#: H561653
Name: Rhynchophylline
CAS#: 76-66-4
Chemical Formula: C22H28N2O4
Exact Mass: 384.20
Molecular Weight: 384.470
Elemental Analysis: C, 68.73; H, 7.34; N, 7.29; O, 16.64
Synonym: Rhynchophylline; Mitrinermine;
IUPAC/Chemical Name: methyl (E)-2-((3R,6'R,7'S,8a'S)-6'-ethyl-2-oxo-2',3',6',7',8',8a'-hexahydro-5'H-spiro[indoline-3,1'-indolizin]-7'-yl)-3-methoxyacrylate
InChi Key: DAXYUDFNWXHGBE-KAXDATADSA-N
InChi Code: InChI=1S/C22H28N2O4/c1-4-14-12-24-10-9-22(17-7-5-6-8-18(17)23-21(22)26)19(24)11-15(14)16(13-27-2)20(25)28-3/h5-8,13-15,19H,4,9-12H2,1-3H3,(H,23,26)/b16-13+/t14-,15-,19-,22+/m0/s1
SMILES Code: O=C1[C@]2(CCN3[C@H]2C[C@H](/C(C(OC)=O)=C\OC)[C@@H](CC)C3)C4=CC=CC=C4N1
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 384.47 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Ng YP, Or TC, Ip NY. Plant alkaloids as drug leads for Alzheimer's disease. Neurochem Int. 2015 Oct;89:260-70. doi: 10.1016/j.neuint.2015.07.018. Epub 2015 Jul 26. Review. PubMed PMID: 26220901.
2: Zhang Q, Zhao JJ, Xu J, Feng F, Qu W. Medicinal uses, phytochemistry and pharmacology of the genus Uncaria. J Ethnopharmacol. 2015 Sep 15;173:48-80. doi: 10.1016/j.jep.2015.06.011. Epub 2015 Jun 17. Review. PubMed PMID: 26091967.
3: Tognolini M, Incerti M, Lodola A. Are we using the right pharmacological tools to target EphA4? ACS Chem Neurosci. 2014 Dec 17;5(12):1146-7. doi: 10.1021/cn500285h. Epub 2014 Nov 18. Review. PubMed PMID: 25405504.
4: Qiu S, Sun H, Zhang AH, Xu HY, Yan GL, Han Y, Wang XJ. Natural alkaloids: basic aspects, biological roles, and future perspectives. Chin J Nat Med. 2014 Jun;12(6):401-6. doi: 10.1016/S1875-5364(14)60063-7. Review. PubMed PMID: 24969519.
5: Zhou JY, Zhou SW. Isorhynchophylline: A plant alkaloid with therapeutic potential for cardiovascular and central nervous system diseases. Fitoterapia. 2012 Jun;83(4):617-26. doi: 10.1016/j.fitote.2012.02.010. Epub 2012 Mar 2. Review. PubMed PMID: 22406453.
6: Zhou J, Zhou S. Antihypertensive and neuroprotective activities of rhynchophylline: the role of rhynchophylline in neurotransmission and ion channel activity. J Ethnopharmacol. 2010 Oct 28;132(1):15-27. doi: 10.1016/j.jep.2010.08.041. Epub 2010 Aug 22. Review. PubMed PMID: 20736055.
7: Shi JS, Yu JX, Chen XP, Xu RX. Pharmacological actions of Uncaria alkaloids, rhynchophylline and isorhynchophylline. Acta Pharmacol Sin. 2003 Feb;24(2):97-101. Review. PubMed PMID: 12546715.
8: Sutter MC, Wang YX. Recent cardiovascular drugs from Chinese medicinal plants. Cardiovasc Res. 1993 Nov;27(11):1891-901. Review. PubMed PMID: 8287391.